This work was limited to verifying the viability and proliferation of the multiple myeloma cell line RPMI8226 in the microgel and the effect of fibronectin on resistance to dexamethasone and bortezomib, in order to show the capability of our 3D environment in the study of multiple myeloma. The gene discussed is FN1; the disease is AL amyloidosis.